The prevalence of antibodies to SARS-CoV-2 among blood donors in China

The prevalence of antibodies to SARS-CoV-2 among blood donors in China

Here, the authors determine seroprevalence of antibodies to SARS-CoV-2 in healthy blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China between January and April 2020. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults is, with 2.66%, the highest i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Le Chang, Wangheng Hou, Lei Zhao, Yali Zhang, Yanbin Wang, Linfeng Wu, Tingting Xu, Lilin Wang, Juan Wang, Jian Ma, Lan Wang, Junpeng Zhao, Jing Xu, Juan Dong, Ying Yan, Ru Yang, Yu Li, Fei Guo, Wenjuan Cheng, Yingying Su, Jinfeng Zeng, Wei Han, Tong Cheng, Jun Zhang, Quan Yuan, Ningshao Xia, Lunan Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/1f8f5aa6ab654b268070bd1fa1d2c896
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f8f5aa6ab654b268070bd1fa1d2c896
record_format dspace
spelling oai:doaj.org-article:1f8f5aa6ab654b268070bd1fa1d2c8962021-12-02T13:32:54ZThe prevalence of antibodies to SARS-CoV-2 among blood donors in China10.1038/s41467-021-21503-x2041-1723https://doaj.org/article/1f8f5aa6ab654b268070bd1fa1d2c8962021-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21503-xhttps://doaj.org/toc/2041-1723Here, the authors determine seroprevalence of antibodies to SARS-CoV-2 in healthy blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China between January and April 2020. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults is, with 2.66%, the highest in Wuhan.Le ChangWangheng HouLei ZhaoYali ZhangYanbin WangLinfeng WuTingting XuLilin WangJuan WangJian MaLan WangJunpeng ZhaoJing XuJuan DongYing YanRu YangYu LiFei GuoWenjuan ChengYingying SuJinfeng ZengWei HanTong ChengJun ZhangQuan YuanNingshao XiaLunan WangNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Le Chang
Wangheng Hou
Lei Zhao
Yali Zhang
Yanbin Wang
Linfeng Wu
Tingting Xu
Lilin Wang
Juan Wang
Jian Ma
Lan Wang
Junpeng Zhao
Jing Xu
Juan Dong
Ying Yan
Ru Yang
Yu Li
Fei Guo
Wenjuan Cheng
Yingying Su
Jinfeng Zeng
Wei Han
Tong Cheng
Jun Zhang
Quan Yuan
Ningshao Xia
Lunan Wang
The prevalence of antibodies to SARS-CoV-2 among blood donors in China
description Here, the authors determine seroprevalence of antibodies to SARS-CoV-2 in healthy blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China between January and April 2020. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults is, with 2.66%, the highest in Wuhan.
format article
author Le Chang
Wangheng Hou
Lei Zhao
Yali Zhang
Yanbin Wang
Linfeng Wu
Tingting Xu
Lilin Wang
Juan Wang
Jian Ma
Lan Wang
Junpeng Zhao
Jing Xu
Juan Dong
Ying Yan
Ru Yang
Yu Li
Fei Guo
Wenjuan Cheng
Yingying Su
Jinfeng Zeng
Wei Han
Tong Cheng
Jun Zhang
Quan Yuan
Ningshao Xia
Lunan Wang
author_facet Le Chang
Wangheng Hou
Lei Zhao
Yali Zhang
Yanbin Wang
Linfeng Wu
Tingting Xu
Lilin Wang
Juan Wang
Jian Ma
Lan Wang
Junpeng Zhao
Jing Xu
Juan Dong
Ying Yan
Ru Yang
Yu Li
Fei Guo
Wenjuan Cheng
Yingying Su
Jinfeng Zeng
Wei Han
Tong Cheng
Jun Zhang
Quan Yuan
Ningshao Xia
Lunan Wang
author_sort Le Chang
title The prevalence of antibodies to SARS-CoV-2 among blood donors in China
title_short The prevalence of antibodies to SARS-CoV-2 among blood donors in China
title_full The prevalence of antibodies to SARS-CoV-2 among blood donors in China
title_fullStr The prevalence of antibodies to SARS-CoV-2 among blood donors in China
title_full_unstemmed The prevalence of antibodies to SARS-CoV-2 among blood donors in China
title_sort prevalence of antibodies to sars-cov-2 among blood donors in china
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1f8f5aa6ab654b268070bd1fa1d2c896
work_keys_str_mv AT lechang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT wanghenghou theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT leizhao theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yalizhang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yanbinwang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT linfengwu theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT tingtingxu theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lilinwang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT juanwang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jianma theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lanwang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT junpengzhao theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jingxu theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT juandong theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yingyan theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT ruyang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yuli theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT feiguo theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT wenjuancheng theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yingyingsu theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jinfengzeng theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT weihan theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT tongcheng theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT junzhang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT quanyuan theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT ningshaoxia theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lunanwang theprevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lechang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT wanghenghou prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT leizhao prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yalizhang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yanbinwang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT linfengwu prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT tingtingxu prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lilinwang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT juanwang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jianma prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lanwang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT junpengzhao prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jingxu prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT juandong prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yingyan prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT ruyang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yuli prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT feiguo prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT wenjuancheng prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT yingyingsu prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT jinfengzeng prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT weihan prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT tongcheng prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT junzhang prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT quanyuan prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT ningshaoxia prevalenceofantibodiestosarscov2amongblooddonorsinchina
AT lunanwang prevalenceofantibodiestosarscov2amongblooddonorsinchina
_version_ 1718392840805941248

Ejemplares similares